Imaging Modalities in Gout: How to Use them in Clinical Practice

References

1. Neogi T, Jansen TLTA, Dalbeth N, et al. 2015 gout classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheumatol. 2015 Oct;67(10):2557–2568.
2. Terslev L, Gutierrez M, Schmidt WA, et al. Ultrasound as an outcome measure in gout. A validation process by the OMERACT Ultrasound Working Group. J Rheumatol. 2015 Nov;42(11):2177–2181.
3. Christiansen SN, Filippou G, Scirè CA, et al. Consensus-based semi-quantitative ultrasound scoring system for gout lesions: Results of an OMERACT Delphi process and web-reliability exercise. Sem Arthritis Rheumatol. 2021 Jun;51(3):644–649.
4. Hammer HB, Karoliussen L, Terslev L, et al. Ultrasound shows rapid reduction of crystal depositions during a treat-to-target approach in gout patients: 12-month results from the NOR-Gout study. Ann Rheum Dis. 2020 Nov;79(11):1500–1505.
5. Singh JA, Budzik JF, Becce F, Pascart T. Dual-energy computed tomography vs ultrasound, alone or combined, for the diagnosis of gout: A prospective study of accuracy. Rheumatology (Oxford). 2021 Oct 2;60(10):4861–4867.
6. Pascart T, Grandjean A, Capon B, et al. Monosodium urate burden assessed with dual-energy computed tomography predicts the risk of flares in gout: A 12-month observational study: MSU burden and risk of gout flare. Arthritis Res Ther. 2018 Sep 17;20(1):210.
7. Ebstein E, Forien M, Norkuviene E, et al. UltraSound evaluation in follow-up of urate-lowering therapy in gout phase 2 (USEFUL-2): Duration of flare prophylaxis. Joint Bone Spine. 2020 Dec;87(6):647–651.